These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6237556)

  • 1. Inhibition of protein synthesis and lymphokine production by tetracycline.
    Ganguly R; Pennock DG; Kluge RM
    Allerg Immunol (Leipz); 1984; 30(2):104-9. PubMed ID: 6237556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines.
    Varesio L; Holden HT; Taramelli D
    J Immunol; 1980 Dec; 125(6):2810-7. PubMed ID: 6159423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lymphocytes produce both leukocyte migration inhibition (LIF) and stimulation (MStF) factors after mitogen, alloantigens or antigen activation.
    Favila-Castillo L; Méndez-Samperio P; Cortés-Castillo MA; Sánchez-Ortega A
    Rev Latinoam Microbiol; 1988; 30(2):111-5. PubMed ID: 3064229
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of migration inhibition factor (MIF) by purified human T cell subpopulations.
    Warrington RJ; Olivier SL; Sauder PJ; Rutherford WJ
    Clin Exp Immunol; 1981 May; 44(2):324-31. PubMed ID: 6458429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular interactions in spontaneous or autologous cell-induced proliferative and lymphokine responses of human lymphocytes.
    Arvilommi H; Räsänen L
    Immunology; 1980 Aug; 40(4):695-700. PubMed ID: 6448804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production.
    Varesio L; Holden HT
    Cell Immunol; 1980 Nov; 56(1):16-28. PubMed ID: 6253087
    [No Abstract]   [Full Text] [Related]  

  • 9. Deficient lymphokine production of newborn lymphocytes.
    Winter HS; Gard SE; Fischer TJ; Bryson YJ; Stiehm ER
    Pediatr Res; 1983 Jul; 17(7):573-8. PubMed ID: 6225985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of lymphocyte activation: macrophage-dependent suppression of T lymphocyte protein synthesis.
    Varesio L; Holden HT
    J Immunol; 1980 Oct; 125(4):1694-701. PubMed ID: 6997385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
    Greineder DK; Rocklin RE; David JR
    J Immunol; 1979 Dec; 123(6):2804-7. PubMed ID: 227960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the production of migration inhibitory factor in humans by tetracycline.
    Ganguly R; Pennock D; Kluge RM
    J Infect Dis; 1983 Sep; 148(3):611. PubMed ID: 6352830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mitogen-induced lymphocyte transformation to assess toxicity of aminoglycosides.
    Metcalf JF; Wilson GB
    J Environ Pathol Toxicol Oncol; 1987; 7(4):27-37. PubMed ID: 3598880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of histamine on leukocyte migration tests in vertebrates. II. Study of the lack of species specificity of leukocyte inhibiting factor--production inhibitor (LIF-PI).
    Rigal D; Monier JC; Mohanna K
    Thymus; 1983; 5(1):53-7. PubMed ID: 6342215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lymphokine resembling transfer factor that stimulates MIF production by nonsensitive lymphocytes.
    Philp JR; McCormack JG; Moore AL; Johnson JE
    J Immunol; 1981 Apr; 126(4):1469-72. PubMed ID: 7009741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomas.
    Cavallo GP; Beatrice F; Poggio E; Bussi M; Di Fortunato V; Rendine S; Sartoris A; Cortesina G
    Boll Ist Sieroter Milan; 1980 May; 59(2):147-54. PubMed ID: 7006629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of specificity of inhibition of polyamine synthesis in bovine lymphocytes by ethylglyoxal bis(guanylhydrazone) and methylglyoxal bis(guanylhydrazone).
    Igarashi K; Porter CW; Morris DR
    Cancer Res; 1984 Nov; 44(11):5326-31. PubMed ID: 6488187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
    Skopińska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of 3 aminoglycoside antibiotics and aztreonam on M.I.F. production by splenic lymphocytes of mice in vitro.
    Said HE; Khalil Y; Sabbour MS
    Chemioterapia; 1984 Aug; 3(4):232-4. PubMed ID: 6398122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous production of an inhibitor in vitro lymphocyte migration by lymphocytes from patients with Hodgkin's disease and mycosis fungoides.
    Skopińska-Rónzewska E; Zółtowska A; Dziewulska-Bokiniec A
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):57-62. PubMed ID: 6756337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.